期刊
CELL TRANSPLANTATION
卷 18, 期 7, 页码 691-693出版社
SAGE PUBLICATIONS INC
DOI: 10.3727/096368909X470883
关键词
Stem cell transplantation; Tissue regeneration, Cellular therapy; Clinical translation
资金
- NHLBI NIH HHS [R01 HL064766, R01HL 64766] Funding Source: Medline
- NINDS NIH HHS [P01 NS42345, P01 NS037520, P01 NS023393, P01 NS37520, R01NS38292, P01-NS042345, 1U01NS055914-01, R01 NS27292, R01 NS027292, R42 NS055606, U01 NS055914, P01 NS23393, R01 NS058784, R01 NS055728, P01 NS042345, R01 NS038292, 2R42NS055606-02] Funding Source: Medline
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064766] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS055914, R01NS055728, P01NS037520, R42NS055606, P01NS023393, R01NS038292, R01NS027292, R01NS058784, P01NS042345] Funding Source: NIH RePORTER
A consortium of translational stem cell and stroke experts from multiple academic institutes and biotechnology companies, under the guidance of the government (FDA/NIH), is missing. Here, we build a case for the establishment of this consortium if cell therapy for stroke is to advance front the laboratory to the clinic
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
